Dafurag Junior is the first drug in the world with furosin (also called furagin) in the form of oral suspension. The product contains furagin at a dose of 10 mg / ml. It is intended primarily for pediatric patients. It is prescribed by a doctor and can be used in children above the age of three months.

Dafurag Junior is the first drug in the world with furosin (also called furagin) in the form of oral suspension. The product contains furagin at a dose of 10 mg / ml. It is intended primarily for pediatric patients. It is prescribed by a doctor and can be used in children above the age of three months. Indications for Dafurag Junior include the treatment of acute and chronic uncomplicated lower urinary tract infections caused by Escherichia coli in children and adults. Phurizidine is an effective and safe substance that has been used for many years in the treatment of lower urinary tract infections. Has antimicrobial effect - eliminates the cause of infection by inhibiting the growth of bacteria that cause lower urinary tract infections. It is also recommended by the Polish Society of Child Nephrology in the prevention of urinary bladder inflammation in children. So far, furazidine was available only as a tablet, which made it difficult for the youngest patients to use it. The form of the suspension increases the child's comfort of taking the medication and facilitates its parent's administration. It also allows precise dosing, which positively affects the effective treatment of urinary tract infections in pediatric patients. We are proud of being the first company in the world to introduce the drug in this form, says Hanna Wahl - Member of the Board, Development Director Aflofarm. Urinary tract infections are the second most common bacterial infection in children. It is estimated that symptoms of urinary tract infection (often referred to as UTI) appear in approximately 8% of girls and 2% of boys up to 7 years of age. Approximately 80% of children with UTI are responsible for Escherichia coli. These infections are most often manifested by fever without a clear cause, painful urination, frequent urination or pain in the lumbar area. At the youngest children can also appear. abdominal pain, colic, vomiting, diarrhea. The marketing authorization was issued on 28.06.2017 by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. The drug was put on sale in August. Aflofarm has been in the prescription drug market since 1998. The Rx segment is one of the priority areas for the company. Aflofarm currently has more than a dozen products in the prescription segment, including Medicines such as Recodium (used to treat cystic myoclonus), Stepcil (used to treat intermittent claudication) or Kidofen Duo (the only combination of ibuprofen and paracetamol in the pediatric form).